Moderators:
Search This Board: 
Created: 12/18/2014 03:13:04 PM - Followers: 85 - Board type: Free - Posts Today: 0


 

Hepion Pharmaceuticals (Nasdaq: $HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV).

Hepion announced top line data from the low dose cohort in the Company's Phase 2a ‘AMBITION' clinical trial of CRV431, an oral, once daily novel cyclophilin inhibitor. This Phase 2a study is continuing with the higher dose of 225 mg CRV431, with NASH patient dosing expected to be completed in Q1-2021.In 2021, of the more than 300 million people living with HBV infection, 10.5% (27 million) were aware of their infection. Non-alcoholic Fatty Liver Disease (NAFLD) affects up to 25% of people in the United States. There are currently no medicines that can cure non-alcoholic Fatty Liver Disease effectively. The same can be said with HBV. With the momentum growing around hepatitis B drug discovery research, we are closer than ever to a cure.

Fact: The inflows have been massive the last 2 weeks. Reason why In just 28 days at the low dose, HEPA CRV431 results were as good as what Madrigal's P3 lead NASH drug took 12 weeks to accomplish.

Bottom line The FDA looks for safety first we have the safest NASH drug our efficacy data is better than MDGL & AKRO. there market caps our almost 10x HEPA. Smart savvy biotech investors with deep pockets know this and are accumulating all they can of HEPA at these levels.
One morning we can wake up and see the price has tripled from its 160 market cap. Also they have 120 million in cash burning under 5 million a quarter. Lots of moving parts here. Gilead & Novo in the mix we will see? A new molecule being added to the pipeline. This management team is experienced 100 years total and world renown experts on cyclophilin inhibitors. They brought a FDA approved blockbuster drug to market already.

June 2021 Hepa Biz Presentation
https://hepionpharma.com/wp-content/uploads/2021/06/Corporate-deck-June-2021-FINAL.pdf

HEPA AI-POWR
https://hepionpharma.com/ai-powr/
HEPA Tackling Chronic Liver Disease - CRV431 Mechanism of Action
https://www.youtube.com/watch?v=CE7es4l1avM

HEPA GLOBAL NASH CONFERENCE PRESENTATION:
https://12ewye24eigk3g5kwa2dxjzm-wpengine.netdna-ssl.com/wp-content/uploads/2021/04/4thGlobal_NASH_Congress_Draft_20Apr2021_FINAL-1.pdf

HEPA website
https://hepionpharma.com

Chairman of the Board, Gary Jacob, is not just a business guy, he's one hell of a biochemist, and you can bet he has a solid grasp of everything that's going on with Hepion.
He's a key player here!

His background goes way beyond what you ordinarily see on the BOD of little R&D biotechs. You might see those with his research background on Scientific Advisory Boards, but they wouldn't have a fraction of the business expertise he's got.
Hepion has the whole package, with this guy!!

Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
https://www.globenewswire.com/news-release/2019/08/07/1898563/0/en/Hepion-Pharmaceuticals-Welcomes-Dr-Stephen-Harrison-to-its-Scientific-Advisory-Board.html

Former Novo Nordisk Executive, Dr. Todd M. Hobbs, Joins Hepion Pharmaceuticals as Chief Medical Officer
Todd Hobbs coming to Hepion. It was published in December. Hobbs' primary focus has always been on diabetes, and I have said many times that there's a blockbuster reason for him leaving his position as Vice President, Chief Medical Officer at Novo Nordisk, a USD 190B global pharmaceutical behemoth, after nearly 17 years there, to come to tiny Hepion.
I believe we'll be hearing about CRV431 in the treatment of diabetes, as it has the highest known potency of any reported cyclophilin inhibitor known, by a wide margin...
https://www.biospace.com/article/releases/former-novo-nordisk-executive-dr-todd-m-hobbs-joins-hepion-pharmaceuticals-as-chief-medical-officer/

Nash Phase 2 & 3 Trials by companies in the space:
AKRO Akero Therapeutics 1.1 Billion Marketcap 240 Million in cash
MDGL Madrigal Pharmaceutical 1.7 Billion Marketcap 300 Million in cash
HEPA Hepion Pharmaceuticals 160 Million market cap 120 million in cash

Currently trading at $2.2 due to a public offering of 44.000.000 shares $2

According to analysts' consensus price target of $80.00, Hepion Pharmaceuticals has a forecasted upside of 3,503.6% from its current price of $2.22.

$HEPA

PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#1948
Keep an eye on this puppy. Just BooDog 09/15/2022 09:43:05 AM
#1947
P2b kick off. BooDog 08/31/2022 09:26:00 AM
#1946
Over 1 year is that considered soon enough bball71 08/24/2022 07:56:33 AM
#1945
I hope this dude didnt drown LMAO CreampieMafia 08/07/2022 12:28:31 AM
#1944
Alot of people have dumped. The thing is CreampieMafia 07/11/2022 10:18:51 AM
#1943
You dump and run? This really turned into Ruffieruff 07/11/2022 06:14:54 AM
#1942
That worked out well. Crime family hard at work. Ruffieruff 06/21/2022 04:23:42 PM
#1941
Hepion Pharmaceuticals Receives FDA Orphan Drug Status Designation threebabiesbusy 06/21/2022 08:21:51 AM
#1940
Who releases news on a holiday? Only a Ruffieruff 06/21/2022 07:24:35 AM
#1939
$HEPA: RencoFilstat gets FDA Orphan Drug Designation makinezmoney 06/21/2022 07:07:07 AM
#1938
Discount. lol most of the market is printing BooDog 05/12/2022 11:10:31 AM
#1937
LMAO CreampieMafia 05/02/2022 03:05:05 PM
#1936
Short squeeze coming as well. Filings next week Ruffieruff 03/25/2022 02:56:22 PM
#1935
Potential breakout in the making. BooDog 03/25/2022 02:42:07 PM
#1934
Just like his money long gone bball71 03/24/2022 05:22:16 PM
#1933
I wonder where the account holder for “fress” CreampieMafia 03/07/2022 05:01:38 PM
#1932
Nice steady increase of late in a challenging market. couldbebetter 03/04/2022 07:11:38 AM
#1931
$CTRVW will pay big here in time. I’m Moose Cat 03/02/2022 08:44:16 PM
#1930
The place to make money with $HEPA is Moose Cat 03/01/2022 03:14:48 PM
#1929
HEPA up 10% what’s going on??? Bertsllc 03/01/2022 12:40:00 PM
#1928
New target price $4.75 Esa 03/01/2022 10:36:10 AM
#1927
Sorry, I was way off, current holdings: Esa 02/10/2022 02:17:47 PM
#1926
HEPA Analyst Ratings Esa 02/10/2022 01:59:20 PM
#1925
Vanguard Group increasing to their position, they hold Esa 02/10/2022 11:57:17 AM
#1924
That’s good. We need you around. I’ve been Ruffieruff 01/27/2022 04:57:59 PM
#1923
Still holding and considering to add soon. StocktraderDK 01/27/2022 04:56:23 PM
#1922
https://seekingalpha.com/article/4480831-hepion-pharmaceuticals-facing-the-momen $pyrodog 01/21/2022 01:00:59 PM
#1921
You’ve vanished just like our Hawaiian buddy. Did Ruffieruff 01/20/2022 07:59:07 PM
#1920
https://investorshub.advfn.com/uimage/uploads/2012/10/25/yscznlmao.gif[/img Bertsllc 01/18/2022 05:51:33 AM
#1919
Still on vacation lol CreampieMafia 01/10/2022 06:16:01 PM
#1918
$HEPA: CRV431 now known as RENCOFILSTAT makinezmoney 01/07/2022 07:35:41 AM
#1917
This has to be one of the toughest Ruffieruff 01/02/2022 08:29:44 AM
#1916
Over sold, i hope so Bertsllc 01/01/2022 08:04:27 PM
#1915
4 more days until tax loss selling ends Bourbon_on_my_cornflakes 12/27/2021 04:18:02 PM
#1914
Someone Big is pounding this stock. A group Bertsllc 12/22/2021 03:50:22 PM
#1913
Here comes the Santa rally, break 1.39 and Esa 12/22/2021 11:59:06 AM
#1912
Give it time. That's good for investors to mpunklil 12/22/2021 11:14:07 AM
#1911
It's a damn shame. Wasting all these good Bertsllc 12/21/2021 09:59:11 AM
#1910
Excellent!! Hepion Pharmaceuticals Announces FDA Clearance of IND BooDog 12/21/2021 09:01:00 AM
#1909
Another sell the news event? Suppression at Ruffieruff 12/21/2021 08:21:54 AM
#1908
Same story every week. Pump then dump. Follow CreampieMafia 12/10/2021 02:04:10 PM
#1907
I was right again CreampieMafia 12/06/2021 12:38:13 PM
#1906
Gona break a new low again today. What CreampieMafia 12/06/2021 09:39:47 AM
#1905
Still in Hawaii bball71 12/04/2021 07:56:48 AM
#1904
Certainly nothing exciting but for a market day BooDog 12/03/2021 04:53:41 PM
#1903
Big fail lol CreampieMafia 12/03/2021 01:20:55 PM
#1902
$HEPA Just so everyone knows that AKRO is StocktraderDK 12/01/2021 05:19:32 PM
#1901
Excellent point Giovanni. Companies apply for fast BooDog 12/01/2021 07:01:06 AM
#1900
What percentage of fast track drugs get approved? Giovanni 11/30/2021 07:56:05 PM
#1899
Robert Foster, PharmD, PhD, Hepion’s CEO, added, “This BooDog 11/30/2021 06:11:15 PM
Post Subject